InMed Pharmaceuticals Inc (IN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

InMed Pharmaceuticals Inc (IN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH140951D
  • |
  • Pages: 48
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based pharmaceutical products to related healthcare markets. The company's pipeline products include INM-750 and INM-085. Its products are used for the treatment of glaucoma, ocular allergies, arthritis, cancer and skin diseases, epidermolysis bullosa, psoriasis and pemphigus vulgaris metabolic syndrome, among others. InMed uses its proprietary platform technology to discover new bioactive compounds within the cannabis plant that interact with certain genes responsible for specific diseases. The company works in partnership with University of British Columbia and University of Debrecen. InMed is headquartered in Vancouver, British Columbia, Canada.

InMed Pharmaceuticals Inc (IN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents

List of Tables

List of Figures

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details

Venture Financing

InMed Pharma Raises USD1.6 Million in Venture Financing

Partnerships

InMed Pharma Enters into Research and Development Agreement with ATERA

InMed Pharma Enters into Agreement with Pharmaseed

Revive Therapeutics to Enter into Agreement with InMed Pharma

InMed Pharma Enters into Agreement with University of Debrecen to Develop Novel Phytocannabinoid Therapies for Ocular Allergies

InMed Pharma Enters into Agreement with University of British Columbia

Cannabis Science Enters into Co-Development Agreement with ImmunoClin

Cannabis Science Enters Into Joint Venture With Dupetit Natural Products

Licensing Agreements

Cannabis Science Enters Into Licensing Agreement With Endocan

Equity Offering

InMed Pharma to Raise USD1.9 Million in Private Placement of Units

InMed Pharma Raises USD1 Million in Private Placement of Units

InMed Pharma Raises USD4.3 Million in Public Offering of Units

InMed Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants

InMed Pharma Raises USD0.2 Million in Private Placement of Units

InMed Pharma to Raise USD0.7 Million in Private Placement of Units

InMed Pharma Raises USD0.83 Million in Private Placement of Units

InMed Pharma Raises USD0.8 Million in Private Placement of Units

Cannabis Science Raises USD1 Million in Private Placement of Shares

Asset Transactions

X-Change Acquires Phytiva Brand Of Products From Cannabis Science

Acquisition

Cannabis Science to Acquire Canada-Based Medical Cannabis Provider

Cannabis Science to Acquire Additional 30.1% Stake in Michigan Green Technologies

X-Change Acquires Germany-Based Joint Venture Company From Cannabis Science And Dupetit Natural Products

Cannabis Science Acquires Trimcare, Provider Of Healthcare Facilities

InMed Pharmaceuticals Inc-Key Competitors

InMed Pharmaceuticals Inc-Key Employees

InMed Pharmaceuticals Inc-Locations And Subsidiaries

Head Office

Recent Developments

Corporate Communications

Mar 06, 2018: Relievant Appoints Christopher Geyen Chief Financial Officer

Mar 02, 2018: InMed Receives Conditional Approval to List on the Toronto Stock Exchange

Oct 10, 2017: InMed Appoints Dr. Mauro Maccarrone to its Scientific Advisory Board

Jan 13, 2017: InMed Pharmaceuticals Appoints Martin Bott to Board of Directors

Product News

Oct 24, 2017: InMed Announces Positive Pre-Clinical Data on an Ocular Hydrogel Formulation using a Biosynthesized Cannabinoid

07/27/2017: InMed Announces Publication in European Journal of Pain

Mar 06, 2018: InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research

Clinical Trials

Oct 17, 2017: InMed Updates Pain Program

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer

List of Figures

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018

List of Tables

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018

InMed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

InMed Pharma Raises USD1.6 Million in Venture Financing

InMed Pharma Enters into Research and Development Agreement with ATERA

InMed Pharma Enters into Agreement with Pharmaseed

Revive Therapeutics to Enter into Agreement with InMed Pharma

InMed Pharma Enters into Agreement with University of Debrecen to Develop Novel Phytocannabinoid Therapies for Ocular Allergies

InMed Pharma Enters into Agreement with University of British Columbia

Cannabis Science Enters into Co-Development Agreement with ImmunoClin

Cannabis Science Enters Into Joint Venture With Dupetit Natural Products

Cannabis Science Enters Into Licensing Agreement With Endocan

InMed Pharma to Raise USD1.9 Million in Private Placement of Units

InMed Pharma Raises USD1 Million in Private Placement of Units

InMed Pharma Raises USD4.3 Million in Public Offering of Units

InMed Pharma Raises USD1 Million in Private Placement of Shares upon Exercise of Warrants

InMed Pharma Raises USD0.2 Million in Private Placement of Units

InMed Pharma to Raise USD0.7 Million in Private Placement of Units

InMed Pharma Raises USD0.83 Million in Private Placement of Units

InMed Pharma Raises USD0.8 Million in Private Placement of Units

Cannabis Science Raises USD1 Million in Private Placement of Shares

X-Change Acquires Phytiva Brand Of Products From Cannabis Science

Cannabis Science to Acquire Canada-Based Medical Cannabis Provider

Cannabis Science to Acquire Additional 30.1% Stake in Michigan Green Technologies

X-Change Acquires Germany-Based Joint Venture Company From Cannabis Science And Dupetit Natural Products

Cannabis Science Acquires Trimcare, Provider Of Healthcare Facilities

InMed Pharmaceuticals Inc, Key Competitors

InMed Pharmaceuticals Inc, Key Employees

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

select a license

Single User License
USD 250 INR 16863
Site License
USD 500 INR 33725
Corporate User License
USD 750 INR 50588

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com